Bioaffinity Technologies Inc.
13F holders, Q3 2024 (September 30)14holders −3
2new positions
5sold out
$2.08avg. 13F price*
At the end of Q3 2024, 14 institutions reported holding Bioaffinity Technologies Inc. in their 13F filings, down 3 from Q2 2024. 2 opened new positions and 5 sold out. The largest holders were Vanguard Group Inc. ($543K), Geode Capital Management, LLC ($181K) and Captrust Financial Advisors ($58K).
- Company
- Bioaffinity Technologies Inc.
- CUSIP
- 09076W109
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $24K |
| Exits | 5 | $120K |
All 13F filers, Q2 2024 → Q3 2024: 126,786 shares bought and 58,690 shares sold, net +68,096 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Vanguard Group Inc. | 0.00% | Add +51.7% | 260,869 | $543K |
| Geode Capital Management, LLC | 0.00% | Add +25.3% | 87,181 | $181K |
| Captrust Financial Advisors | 0.00% | No change | 27,885 | $58K |
| Sheaff Brock Investment Advisors, LLC | 0.00% | Add +33.3% | 20,000 | $42K |
| State Street Corp. | 0.00% | No change | 17,600 | $37K |
| Northern Trust Corp. | 0.00% | No change | 13,662 | $28K |
| Creative Planning | 0.00% | Reduce -4.0% | 12,095 | $25K |
| XTX Topco Ltd | 0.00% | New | 11,264 | $23K |
| IFP Advisors, Inc | 0.00% | No change | 10,000 | $21K |
| Morgan Stanley | 0.00% | Add +396.1% | 4,961 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -54.8% | 2,085 | $4K |
| Clear Street LLC | 0.00% | New | 100 | $208 |
| Bank of America Corp. | 0.00% | Add +3.1% | 67 | $139 |
| JPMorgan Chase & Co. | 0.00% | Add +16.7% | 21 | $44 |
"% of holder's portfolio" is BIOAFFINITY TECHNOLOGIES INC's weight in each manager's 13F, not the share of Bioaffinity Technologies Inc. the manager owns.